Pillstats
Rx only · Tablet · Oral

Lorazepam

Brands: Ativan · Lorazepam

27 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US118 NDCs
27 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)6470
US makers28 labelers
Packages459
DEA / ScheduleCIV

US acquisition costNADAC · per unit

Average across 50 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.015$0.031$0.046$0.061Dec 2025Apr 2026Jul 2026
$0.045
Latest avg · Jul 22, 2026
-15%
Since Dec 17, 2025
27
Active US suppliers
48%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

298K596K894K1.2M2025 Q12025 Q22025 Q32025 Q42026 Q1
932K
Rx · 2026 Q1
37.8M
Units dispensed
-9%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it27 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Aphena Pharma Solutions - Tennessee, LLCunknown165SUPPLYING
Bryant Ranch Prepackrepackager54SUPPLYING
NuCare Pharmaceuticals, Inc.unknown29SUPPLYING
Proficient Rx LPunknown25SUPPLYING
REMEDYREPACK INC.repackager22SUPPLYING
Asclemed USA, Inc.unknown22SUPPLYING
PD-Rx Pharmaceuticals, Inc.unknown21SUPPLYING
Preferred Pharmaceuticals Inc.unknown15SUPPLYING
Aurolife Pharma, LLCunknown12SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown12SUPPLYING
Rising Pharma Holdings, Inc.unknown9SUPPLYING
Leading Pharma, LLCunknown9SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown9SUPPLYING
ANI Pharmaceuticals, Inc.unknown9SUPPLYING
A-S Medication Solutionsunknown8SUPPLYING

+ 13 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jan 21, 2025
    RECALLRecall (Class II): Lorazepam Tablets, USP, 2mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drug product conta…

    Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities. — Recalling firm: The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories — Nationwide U.S. and Puerto rico

  • Jan 21, 2025
    RECALLRecall (Class II): Lorazepam Tablets, USP, 1mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drug product conta…

    Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities. — Recalling firm: The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories — Nationwide U.S. and Puerto rico

  • Jan 21, 2025
    RECALLRecall (Class II): Lorazepam Tablets, USP, 0.5mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drug product con…

    Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities. — Recalling firm: The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories — Nationwide U.S. and Puerto rico

  • Sep 28, 2017
    RECALLRecall (Class II): Lorazepam Tablets, USP CIV, 0.5 mg, 500-count bottle, Rx Only, Manufactured by: Leading Pharma, LLC Fairfield, NJ 07004…

    Labeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets of lorazepam — Recalling firm: Leading Pharma, LLC — Nationwide in the USA

  • Mar 27, 2013
    RECALLRecall (Class III): Lorazepam, 0.5 mg tablets, 100 count, RX only, Distributed by Major Pharmaceuticals, Livonia, MI. NDC 0904-6007-60

    Labeling: Incorrect or Missing Lot and/or Exp Date: Lorazepam Lot # L-04009 — Recalling firm: Legacy Pharmaceutical Packaging LLC — Distribution was made to IN.